Answer
Yes, ertugliflozin (Steglatro) is a potent, selective and reversible inhibitor of SGLT2.
Sources for this answer
- Steglatro 5 mg and 15 mg film-coated tabletsMerck Sharp & Dohme (UK) Limited · emc · SmPC §5.1 Pharmacodynamic properties · Version 9Document updated
Sources checked